APACHE II severity of disease classification (also searched with possessive/alternate eponym spelling where applicable, ICD-10: Z91.89) is an extensively validated and widely utilised prognostic scoring system applied within critical care environments to evaluate the severity of acute illness in hospitalized patients1. Developed by Knaus et al., the APACHE II (Acute Physiology and Chronic Health Evaluation II) classification simplifies the earlier APACHE system by reducing the number of physiological variables from 34 to 12 while incorporating adjustments for patient age and chronic health status1. By quantifying the degree of acute physiological derangement during the first 24 hours of admission, the tool generates a numerical score that correlates closely with the risk of inpatient mortality, serving as an objective benchmark for clinical evaluation, quality assessment, and epidemiological research in intensive care medicine1.

Etiology & Risk Factors

  • Critical Illness States: Severe sepsis, septic shock, acute respiratory distress syndrome (ARDS), multi-organ dysfunction syndrome (MODS), and severe metabolic derangements1.
  • Traumatic and Surgical Stress: Major polytrauma, severe burns, emergency post-operative states, and intracranial catastrophe requiring intensive care monitoring1.
  • Cardiovascular Emergencies: Complicated myocardial infarction, acute decompensated heart failure, cardiogenic shock, and malignant arrhythmias1.
  • Chronic Comorbidities (Chronic Health Points): Immunocompromised states, chronic obstructive pulmonary disease (COPD), end-stage renal disease on dialysis, decompensated chronic liver disease (cirrhosis with portal hypertension), and severe New York Heart Association (NYHA) Class IV heart failure1.
  • Advanced Age: Incremental age brackets that progressively contribute to baseline mortality risk scoring within the classification framework1.

Pathophysiology

The pathophysiological foundation underlying the APACHE II scoring mechanism involves the progressive systemic response to severe physiological stress, injury, or infection1. When a primary insult occurs, the body initiates complex neuroendocrine, inflammatory, and immune cascades. Systemic inflammatory response syndrome (SIRS) or compensatory anti-inflammatory response syndrome (CARS) can lead to endothelial injury, capillary leak, microvascular thrombosis, and profound cellular hypoxia. As perfusion fails or metabolic demands outstrip supply, individual organ systems begin to fail sequentially or simultaneously, culminating in multi-organ dysfunction syndrome (MODS)1. The 12 physiological variables measured in APACHE II—such as mean arterial pressure, heart rate, respiratory rate, temperature, arterial blood gas parameters (pH, PaO2 or AaDO2), serum electrolytes (sodium, potassium), creatinine, hematocrit, white blood cell count, and Glasgow Coma Scale—directly reflect the functional integrity of the cardiovascular, respiratory, renal, neurological, and hematopoietic systems under acute stress. Derangements in these parameters signify failing homeostatic mechanisms, enabling clinicians to quantify the depth of physiological collapse and predict clinical trajectory1.

APACHE II severity of disease classification — Pathophysiological Cascade & Clinical Flowchart 1 Physiological Insult Acute systemic stress, infection, trauma, or organ failure triggers widespread neuroendocrine and inflammatory responses. 2 Systemic Derangement Cellular hypoxia, cytokine release, and metabolic acidosis lead to multi-organ dysfunction syndrome (MODS). 3 Data Collection Quantifying acute physiological abnormalities, acid-base imbalances, and laboratory markers within the initial 24 hours. 4 Score Computation Integrating acute physiological variables, age points, and chronic health points to derive the cumulative APACHE II score. 5 Risk Stratification Correlating the numerical score with predicted hospital mortality to guide clinical management and resource allocation.

Clinical Presentation & Classic Clinical Signs

  • History & Cardinal Symptoms: Acute onset of profound dyspnoea, altered mental status, oliguria or anuria, generalized weakness, chest pain, severe abdominal pain, or systemic symptoms of infection such as high fever or rigours. Patients typically present with a history of rapid clinical deterioration over hours to days.
  • Physical Examination & Named Clinical Signs: Tachycardia, tachypnoea, hypotension or wide pulse pressure variability, peripheral vasoconstriction with cool extremities, delayed capillary refill, cyanosis, petechiae or purpura in coagulopathies, and neurological deficits or depressed level of consciousness as quantified by the Glasgow Coma Scale (GCS). Signs of specific underlying organ failure, such as pulmonary crackles, wheezes, abdominal guarding, or jaundice, are frequently present.

Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)

Diagnostic Modality / Test Expected Clinical & Radiological / Laboratory Finding
Gold-Standard InvestigationComprehensive 24-hour physiological data extraction and calculation of the cumulative APACHE II score using worst recorded parameters.
Laboratory PanelArterial blood gases (pH, PaO2, HCO3), complete blood count (leukocytosis or leukopenia, low haematocrit), comprehensive metabolic panel (elevated serum creatinine, blood urea nitrogen, abnormal serum sodium and potassium).
Imaging / Radiology (X-ray, US, CT, MRI)Chest radiography demonstrating pulmonary edema, infiltrates, or ARDS changes; focused bedside ultrasound (FAST, echocardiography) evaluating cardiac contractility and volume status; CT imaging identifying acute intracranial pathology, visceral perforation, or ischemic bowel.
ECG / Histopathology / Procedural12-lead ECG revealing ischemic changes, conduction abnormalities, or signs of acute cor pulmonale; continuous haemodynamic monitoring data; microbiological cultures identifying the infectious source.

Staging, Classification & Clinical Scoring Systems

Criterion / Stage / Score Component Clinical Threshold, Points & Management Implication
Acute Physiology Score (APS)Derived from 12 routine physiological measurements evaluated at their worst values during the first 24 hours of ICU admission; ranges from 0 to 60 points based on the magnitude of deviation from normal physiological ranges.
Age PointsAssigned based on patient age: ≤44 years (0 pts), 45–54 years (2 pts), 55–64 years (3 pts), 65–74 years (5 pts), ≥75 years (6 pts). Reflects baseline physiological reserve.
Chronic Health PointsAdds 5 points for non-operative or emergency post-operative patients, or 2 points for elective post-operative patients, who have a history of severe organ system insufficiency (liver, cardiovascular, respiratory, renal) or immunocompromise.
Total APACHE II Score & Mortality CorrelationCumulative sum (APS + Age + Chronic Health); scores range from 0 to 71. Higher scores correlate exponentially with predicted hospital mortality rates, guiding resource allocation and goals-of-care discussions.

Differential Diagnosis

Differential Condition Distinguishing Clinical, Biochemical & Imaging Features
Sepsis and Septic ShockDefined by infection source and refractory hypotension requiring vasopressors; elevated lactate, leukocytosis or neutropenia, and positive blood cultures.
Acute Respiratory Distress Syndrome (ARDS)Non-cardiogenic pulmonary edema with PaO2/FiO2 ratio ≤300 mmHg, bilateral infiltrates on chest imaging, and acute onset within 1 week of a known clinical insult.
Multi-Organ Dysfunction Syndrome (MODS)Progressive dysfunction of two or more organ systems following an acute physiological insult, where homeostasis cannot be maintained without active medical intervention.
Severe Metabolic EncephalopathyAltered mental status secondary to uremia, hepatic failure, electrolyte imbalances, or severe hypoxia, differentiated from primary neurological injury by systemic biochemical abnormalities.

Management & Treatment Protocol

  • Initial Stabilization & Resuscitation: Immediate airway management, mechanical ventilation for acute respiratory failure, and aggressive goal-directed hemodynamic resuscitation using crystalloid fluids and vasopressors (e.g., norepinephrine infusion titrated to maintain a mean arterial pressure ≥65 mmHg)1.
  • First-Line Medical / Pharmacological Therapy (with exact adult dosing): Broad-spectrum intravenous antimicrobials administered within the first hour for suspected sepsis (e.g., piperacillin-tazobactam 4.5 g IV every 6 hours or meropenem 1 g IV every 8 hours, combined with vancomycin 15–20 mg/kg IV every 8–12 hours adjusted for renal function); stress ulcer prophylaxis with pantoprazole 40 g IV once daily; and targeted glycemic control with regular insulin infusions maintaining blood glucose between 140–180 mg/dL.
  • Surgical / Interventional Indications: Urgent surgical source control for intra-abdominal perforation, necrotizing soft tissue infection, abscess drainage, or emergency decompression of compartment syndromes.

Complications & Prognosis

  • Key Acute and Chronic Complications: Persistent multi-organ failure, secondary nosocomial infections (ventilator-associated pneumonia, catheter-related bloodstream infections), critical illness myopathy and neuropathy, acute kidney injury requiring renal replacement therapy, and chronic physical and cognitive impairment (post-intensive care syndrome)1.
  • Mortality and Prognostic Factors: Inpatient mortality increases sharply as the APACHE II score rises; a score under 10 generally correlates with a predicted mortality below 15%, whereas scores exceeding 30–35 are associated with predicted mortality rates surpassing 75% to 85%1. Prognosis is heavily influenced by the reversibility of the underlying precipitating condition, baseline physiological reserve, and age1.